Beckman Coulter has announced that it will be offering Trillium Diagnostics products in North America and South America, as well as in the majority of Europe, Asia and Australasia.
Trillium Diagnostics products covered include assays for feto-maternal haemorrhage testing (Fetaltrol control) and cellular HbF level quantitation (FMH Quikquant), as well as Leuko64, which is used for sepsis and infection detection by flow cytometry.
Beckman Coulter will now be able to provide diagnostic laboratories and research institutes with targeted flow cytometry products that address specific unmet medical needs.